Chromosomal aberrations in workers exposed to low levels of benzene: Association with genetic polymorphisms

Pharmacogenetics

Volumn 14, Issue 7, 2004, Pages 453-463

  Su, Young Kim ^a   Jung, Keun Choi ^b   Yoon, Hee Cho ^a   Eun, Jung Chung ^a   Paek, Domyung ^a   Hai, Won Chung ^a  

^a Seoul National University   (South Korea)

^b Korea Occupational Safety and Health Agency   (South Korea)

Author keywords

Aneuploidy; Benzene; Genetic polymorphism; Translocation

Indexed keywords

ALCOHOL; BENZENE; GLUTATHIONE TRANSFERASE;

ADULT; ALCOHOL CONSUMPTION; ANEUPLOIDY; ARTICLE; CHROMOSOME 21; CHROMOSOME 8; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; GEOMETRY; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOSOMY; MULTIPLE REGRESSION; PRIORITY JOURNAL; SMOKING; TRISOMY;

ANEUPLOIDY; CHROMOSOME ABERRATIONS; ENZYMES; HUMANS; OCCUPATIONAL EXPOSURE; POLYMORPHISM, GENETIC; TRISOMY;

EID: 3242748904     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fpc.0000114751.08559.7b     Document Type: Article

References (43)

1. Drummond L, Luck R, Afacan AS, Wilson HK. Biological monitoring of workers exposed to benzene in the coke oven industry. Br J Ind Med 1988; 45:256-261.
2. Krewski D, Snyder R, Beatty P, Granville G, Meek B, Sonawane B. Assessing the health risks of benzene: a report on the benzene state-of-the-science workshop. J Toxicol Environ Health Part A 2000; 61:307-338.
3. Ross D. The role of metabolism and specific metabolites in benzene-induced toxicity: evidence and issues. J Toxicol Environ Health Part A 2000; 61:357-372.
4. Inoue O, Seiji K, Kasahara M, Nakatsuka H, Watanabe T, Yin SG, et al. Determination of catechol and quinol in the urine of workers exposed to benzene. Br J Ind Med 1988; 45:487-492.
5. Smith MT. The mechanism of benzene-induced leukemia: a hypothesis and speculations on the causes of leukemia. Environ Health Perspect Suppl 1996; 6:1219-1225.
6. Smith MT, Yager JW, Steinmetz KL, Eastmond DA. Peroxidase-dependent metabolism of benzene's phenolic metabolites and its potential role in benzene toxicity and carcinogenicity. Environ Health Perspect 1989; 82:23-29.
7. Larson RA, Wang Y, Banerjee M, Wiemels J, Hartford C, Le Beau MM. Prevalence of the inactivating 609C>T polymorphism in the NAD(P)H: quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia. Blood 1999; 94:803-807.
8. Erexson GL, Wilmer JL, Kligerman AD. Sister chromatid exchange induction in human lymphocytes exposed to benzene and its metabolites in vitro. Cancer Res 1985; 45:2471-2477.
9. Yager JW, Eastmond DA, Robertson ML, Paradisin WM, Smith MT. Characterization of micronuclei induced in human lymphocytes by benzene metabolites. Cancer Res 1990; 50:393-399.
10. Zhang L, Robertson ML, Kolachana P, Davison AJ, Smith MT. Benzene metabolite, 1,2,4-benzenetriol, induces micronuclei and oxidative DNA damage in human lymphocytes and HL60 cells. Environ Mol Mutagen 1993; 21:339-348.
11. Zhang L, Venkatesh P, Creek ML, Smith MT. Detection of 1,2,4-benzenetriol induced aneuploidy and microtubule disruption by fluorescence in situ hybridization and immunocytochemistry. Mutation Res 1994; 320:315-327.
12. Zhang L, Wang Y, Shang N, Smith MT. Benzene metabolites induce the loss and long arm deletion of chromosomes 5 and 7 in human lymphocytes. Leuk Res 1998; 22:105-113.
13. Stillman WS, Varella-Garcia M, Gruntmeir JJ, Irons RD. The benzene metabolite, hydroquinone, induces dose-dependent hypoploidy in a human cell line. Leukemia 1997; 11:1540-1545.
14. Stillman WS, Varella-Garcia M, Irons RD. The benzene metabolite, hydroquinone, selectively induces 5q31- and -7 in human CD34+CD19-bone marrow cells. Exp Hematol 2000; 28:169-176.
15. Chung HW, Kim SY. Detection of chromosome-specific aneusomy and translocation by benzene metabolites in human lymphocytes using fluorescence in situ hybridization with DNA probes for chromosomes 5,7,8, and 21. J Toxicol Environ Health Part A 2002; 65:365-372.
16. Smith MT, Zhang L, Wang Y, Hayes RB, Li G, Wiemels J, et al. Increased translocations and aneusomy in chromosomes 8 and 21 among workers exposed to benzene. Cancer Res 1998; 58:2176-2181.
17. Smith MT, Rothman N. Biomarkers in the molecular epidemiology of benzene-exposed workers. J Toxicol Environ Health Part A 2000; 61:439-445.
18. Zhang L, Rothman N, Wang Y, Hayes RB, Yin S, Titenko-Holland N, et al. Benzene increases aneuploidy in the lymphocytes of exposed workers: a comparison of data obtained by fluorescence in situ hybridization in interphase and metaphase cells. Environ Mol Mutagen 1999; 34:260-268.
19. Pavanello S, Clonfero E. Biological indicators of genotoxic risk and metabolic polymorphisms. Mutation Res 2000; 463:285-308.
20. Gobba F, Rovesti S, Borella P, Vivoli R, Caselgrandi E, Vivoli G. Interindividual variability of benzene metabolism to trans, trans-muconic acid and its implications in the biological monitoring of occupational exposure. Sci Total Environ 1997; 199:41-48.
21. Smith MT. Overview of benzene-induced aplastic anaemia. Eur J Haematol 1996; 60 (suppl):107-110.
22. Kato S, Onda M, Matsukura N, Tokunaga A, Tajiri T, Kim DY, et al. Cytochrome P4502E1 (CYP2E1) genetic polymorphism in a case-control study of gastric cancer and liver disease. Pharmacogenetics 1995; 5:S141-S144.
23. Xu X, Wiencke JK, Niu T, Wang M, Watanabe H, Kelsey KT, et al. Benzene exposure, glutathione S-transferase theta homozygous deletion, and sister chromatid exchanges. Am J Ind Med 1998; 33:157-163.
24. Stucker I, Hirvonen A, de Waziers I, Cabelguenne A, Mitrunen K, Cenee S, et al. Genetic polymorphisms of glutathione S-transferases as modulators of lung cancer susceptibility. Carcinogenesis 2002; 23:1475-1481.
25. Laso N, Lafuente MJ, Mas S, Trias M, Ascaso C, Molina R, et al. Glutathione S-transferase (GSTM1 and GSTT1)-dependent risk for colorectal cancer. Anticancer Res 2002; 22:3399-3403.
26. Morari EC, Leite JL, Granja F, da Assumpcao LV, Ward LS. The null genotype of glutathione S-transferase M1 and T1 locus increases the risk for thyroid cancer. Cancer Epidemiol Biomarkers Prev 2002; 11:1485-1488.
27. Raunio H, Husgafvel-Pursiainen K, Anttila S, Hietanen E, Hirvonen A, Pelkonen O. Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility - a review. Gene 1995; 159:113-121.
28. International Atomic Energy Agency. Biological Dosimetry: Chromosome Aberration Analysis for Dose Assessment. IAEA Technical Report 260; Vienna: IAEA; 1986, pp. 59-63.
29. Comstock KE, Sanderson BJS, Claflin G, Henner WD. GST1 gene deletion determined by polymerase chain reaction. Nucl Acids Res 1990; 18:3670.
30. Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, et al. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 1994; 300:271-276.
31. Harries LW, Stubbins MJ, Forman D, Howard GCW, Wolf CR. Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 1997; 18:641-644.
32. Bell DA, Taylor JA, Butler MA, Stephens EA, Wiest J, Brubaker LH, et al. Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans. Carcinogenesis 1993; 14:1689-1692.
33. Wang SL, Lee H, Chen KW, Tsai KJ, Chen CY, Lin P. Cytochrome P4502E1 genetic polymorphism and lung cancer in a Taiwanese population. Lung Cancer 1999; 26:27-34.
34. Wang X, Chen D, Niu T, Wang Z, Wang L, Ryan L, et al. Genetic susceptibility to benzene and shortened gestation: evidence of gene-environment interaction. Am J Epidemiol 2000; 152:693-700.
35. Mitelman F, Brandt L, Nilsson PG. Relation among occupational exposure to potential mutagenic/carcinogenic agents, clinical findings, and bone marrow chromosomes in acute nonlymphocytic leukemia. Blood 1978; 52:1229-1237.
36. Mitelman F, Nilsson PG, Brandt L, Alimena G, Gastaldi R, Dallapiccola B. Chromosome pattern, occupation, and clinical features in patients with acute nonlymphocytic leukemia. Cancer Genet Cytogenet 1981; 4:197-214.
37. Crane MM, Keating MJ, Trujillo JM, Labarthe DR, Frankowski RF. Environmental exposures in cytogenetically defined subsets of acute nonlymphocytic leukemia. J Am Med Assoc 1989; 262:634-639.
38. Pedersen-Bjergaard J, Rowley JD. The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation. Blood 1994; 83:2780-2786.
39. Vineis P. Diet, genetic susceptibility and carcinogenesis. Public Health Nutr 2001; 4:485-491.
40. Witz G, Zhang Z, Goldstein BD. Reactive ring-opened aldehyde metabolites in benzene hematotoxicity. Environ Health Perspect 1996; 104 (suppl 6):1195-1199.
41. Rossi AM, Guarnieri C, Rovesti S, Gobba F, Ghittori S, Vivoli G, et al. Genetic polymorphisms influence variability in benzene metabolism in humans. Pharmacogenetics 1999; 9:445-451.
42. Quinones L, Berthou F, Varela N, Simon B, Gil L, Lucas D. Ethnic susceptibility to lung cancer: differences in CYP2E1, CYP1A1 and GSTM1 genetic polymorphisms between French Caucasian and Chilean populations. Cancer Lett 1999; 141:167-171.
43. Moran JL, Siegel D, Ross D. A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H: quinone oxidoreductase 1 (NQO1) to benzene toxicity. Proc Natl Acad Sci USA 1999; 96:8150-8155.